Clinical characteristics | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
---|---|---|---|---|
Age, years | 13 | 14 | 14 | 14 |
Sex | Male | Male | Female | Female |
History of contact | Present | Absent | Absent | Absent |
Comorbidities | No | Type 1 DM | No | No |
Time to presentation, days | 5 | 6 | 10 | 7 |
Disease severity | Severe | Mild | Mild | Severe |
Body temperature, oF | 102.3 (↑) | 101.3 (↑) | 100.4 (↑) | 101.7 (↑) |
Respiratory rate, per min | 32 (↑) | 30 (↑) | 22 (N) | 28 (↑) |
Heart rate, per min | 130 (↑) | 110 (↑) | 108 (↑) | 118 (↑) |
Blood pressure, mmHg | 80/60 (↓) | 100/60 (N) | 90/60 (N) | 70/40 (↓) |
SpO2 on RA, % | 85 (↓) | 95 (N) | 99 (N) | 83 (↓) |
COVID-19 RT-PCR | Negative | Negative | Negative | Negative |
COVID-19 IgG Titer, U/ml | 250 (↑) | 131 (↑) | 88 (↑) | 72 (↑) |
Hb levels, gm/dl | 12.4 (N) | 9.9 (↓) | 10 (↓) | 10.7 (↓) |
Leucocyte count, cells/μl | 15700 (↑) | 16300 (↑) | 1700 (N) | 5400 (N) |
Platelets, cells/μl | 95000 (↓) | 151000 (N) | 71000 (↓) | 97000 (↓) |
Neutrophils, cells/μl | 20.8 (↑) | 80 (↑) | 56 (↑) | 83 (↑) |
Lymphocytes, cells/μl | 9.16 (↑) | 16 (↑) | 38 (↑) | 11.3 (↑) |
C-reactive protein, mg/L | 110 (↑) | 107.9 (↑) | 84.1 (↑) | 123 (↑) |
ESR, mm/hr | 54 (↑) | 60 (↑) | 47 (↑) | 56 (↑) |
Procalcitonin, ng/ml | 0.10 (↑) | 0.16 (↑) | 0.08 (N) | 0.12 (↑) |
LDH, IU/l | 352 (↑) | 888 (↑) | 628 (↑) | 560 (↑) |
D dimer, μg/l | 4060 (↑) | 9640 (↑) | 2633 (↑) | 1300 (↑) |
INR | 1.44 (↑) | 1.21 (↑) | 1.1 (N) | 1.12 (N) |
Fever profile | Negative | Negative | Negative | Negative |
Blood culture | Negative | Negative | Negative | Negative |
Urine culture | Negative | Negative | Negative | Negative |
Liver function test | WNL | WNL | WNL | WNL |
Renal function test | WNL | WNL | WNL | WNL |
X-ray chest | WNL | WNL | WNL | WNL |
HRCT chest | WNL | WNL | ND | ND |
ECG | Sinus Tachycardia | Sinus Tachycardia | Sinus Tachycardia | Sinus Tachycardia |
2D ECHO | WNL | WNL | Mild global hypokinesia | Biventricular dysfunction, mild pericardial effusion |
Hospital stay, days | 2 | 10 | 7 | 10 |